Literature DB >> 21907304

Neglected and emerging fungal infections: review of hyalohyphomycosis by Paecilomyces lilacinus focusing in disease burden, in vitro antifungal susceptibility and management.

Paulo R Z Antas1, Marcelly M S Brito, Érika Peixoto, Carlos G G Ponte, Cíntia M Borba.   

Abstract

Paecilomyces lilacinus is an emerging pathogenic fungus that can cause different clinical manifestations ranging from cutaneous and sub-cutaneous infections to severe oculomycosis. This review discusses infections caused by P. lilacinus, as well as their symptoms and correlates of immune responses, morphological characteristics of the fungus, therapies, in vitro susceptibility tests, laboratory diagnosis and the experimental models available.
Copyright © 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21907304     DOI： 10.1016/j.micinf.2011.08.004

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  13 in total

1.  Assessment of multi-contaminant exposure in a cancer treatment center: a 2-year monitoring of molds, mycotoxins, endotoxins, and glucans in bioaerosols.

Authors:  Natacha Heutte; Véronique André; Catherine Dubos Arvis; Valérie Bouchart; Françoise Lemarié; Patrick Legendre; Edwige Votier; Marie-Yolande Louis; Stéphane Madelaine; Virginie Séguin; Stéphanie Gente; Philippe Vérité; David Garon
Journal:  Environ Monit Assess       Date:  2016-12-23       Impact factor: 2.513

2.  Fatal Purpureocillium lilacinum pneumonia in a green tree python.

Authors:  Jean Meyer; Igor Loncaric; Barbara Richter; Joachim Spergser
Journal:  J Vet Diagn Invest       Date:  2017-12-22       Impact factor: 1.279

3.  Purpureocillium lilacinum tattoo-related skin infection in a kidney transplant recipient.

Authors:  Sonya A Trinh; Michael P Angarone
Journal:  Transpl Infect Dis       Date:  2017-04-13       Impact factor: 2.228

Review 4.  Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.

Authors:  Matheus Aparecido Dos Santos Ramos; Patrícia Bento Da Silva; Larissa Spósito; Luciani Gaspar De Toledo; Bruna Vidal Bonifácio; Camila Fernanda Rodero; Karen Cristina Dos Santos; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2018-02-27

5.  Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.

Authors:  Frédéric Lamoth; Barbara D Alexander
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

6.  Paecilomyces variotii Fungemia in a Patient with Lymphoma Needing Liver Transplant.

Authors:  A P Bellanger; J P Cervoni; J F Faucher; D Weil-Verhoeven; M Ginet; E Deconinck; F Grenouillet
Journal:  Mycopathologia       Date:  2017-04-01       Impact factor: 2.574

7.  Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate.

Authors:  Ziauddin Khan; Suhail Ahmad; Fahad Al-Ghimlas; Sana Al-Mutairi; Leena Joseph; Rachel Chandy; Deanna A Sutton; Josep Guarro
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

Review 8.  Use of voriconazole for the treatment of Paecilomyces lilacinus cutaneous infections: case presentation and review of published literature.

Authors:  Ramzy H Rimawi; Yvonne Carter; Thomas Ware; John Christie; Dawd Siraj
Journal:  Mycopathologia       Date:  2013-01-20       Impact factor: 2.574

9.  Occurrence of fruiting structures allows determination of Purpureocillium lilacinum as an inciting agent of pleuritis and pneumonia in a loggerhead sea turtle (Caretta caretta) by histopathologic correlation to culture.

Authors:  V L Schumacher; B Mangold; J Lenzycki; L Hinckley; D A Sutton; S Frasca
Journal:  Med Mycol Case Rep       Date:  2014-09-16

10.  Experimental Hyalohyphomycosis by Purpureocillium lilacinum: Outcome of the Infection in C57BL/6 Murine Models.

Authors:  Danielly C M de Sequeira; Rodrigo C Menezes; Manoel M E Oliveira; Paulo R Z Antas; Paula M De Luca; Joseli de Oliveira-Ferreira; Cintia de Moraes Borba
Journal:  Front Microbiol       Date:  2017-08-23       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.